Re older Cheeky Scientist contracts: I'm still interested in hearing from anyone who has had the 'non-disparagement' section of their contract enforced, or has been threatened with enforcement of that section. You can reach me at coffordwrites[at]gmail[dot]com
Cheeky Scientist bills itself on its website as the “world’s premier career training platform for PhDs.”
However, many customers allege they were pushed into purchasing services they didn’t want, can’t afford, and haven’t used. https://t.co/mnvFQHDtNJ
The Trump administration says it is "not possible" for it to comply with a court order to release hundreds of millions of dollars in aid funds by midnight tonight.
This and more in the @NewsfromScience Trump Tracker:
https://t.co/y65P8Gescg
The chaos at USAID has left many clinical trials in limbo. We spoke to the researchers now scrambling to protect the staff and volunteers involved.
https://t.co/Jt139o1dRn
Cheeky Scientist update: Today, Affirm, the company that used to provide loans for #CheekyScientist customers, told me they are refunding all customers who have opened a dispute. They say:
Electronic refunds should have already been processed to the consumers’ original payment method, and refunds by check should be in the mail as of today.”
*Please share this with anyone who might find it useful!*
Today the @uk_biobank is releasing ~500K whole genome sequences. A tremendous feat in (1) enormity and (2) data sharing. https://t.co/vJ0P6RsC2C @ScienceMagazine@ce_offord
My latest investigation for @newsfromscience: Star neuroscientist Berislav Zlokovic of @KECKSchool_USC implicated in possible misconduct involving apparent data doctoring going back 25+ years. Includes science behind a stroke drug in major human trials 1/5 https://t.co/aLuQ5lVD0K
Campus labor organizing efforts are rising across the country—forcing the academic community to reckon with how it compensates early career researchers and what the future of academic science will look like. https://t.co/Q5SfljwDZ3
Congratulations to @cpiller, winner of an Eric and Wendy Schmidt Award for Excellence in Science Communications in the Science Journalist: Freelancer category. @SciCommAwards https://t.co/6p0oV2HnSD 🏆
Here’s a look at his winning stories. (THREAD 🧵)
I’m honored to be a winner of the National Academies/Schmidt Award for Excellence in Science Communications, for stories highlighting signs of misconduct in Alzheimer’s research thanks to courageous whistleblowers like @schrag_matthew#sciencejournalism @scicommexcellence
My latest: Long-awaited CUNY investigation finds that Hoau-Yan Wang, a key scientist behind Cassava Sciences’ Alzheimer’s drug, engaged in “longstanding and egregious misconduct” associated with studies supporting the drug, simufilam. 1/3 https://t.co/rYqpkO4Mos